Albireo Pharma (ALBO)

Albireo Pharma (ALBO) Stock Price & Analysis


ALBO Stock Chart & Stats

Day’s Range$43.99 - $44.9
52-Week Range― - ―
Previous Close$44.25
Average Volume (3M)N/A
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
Shares Outstanding20,744,886
10 Day Avg. Volume457,357
30 Day Avg. Volume703,772
Standard Deviation0.19
Financial Highlights & Ratios
Price to Book (P/B)10.95
Price to Sales (P/S)36.48
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-8.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside-0.79% Downside
Rating ConsensusHold
Number of Analyst Covering6



Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Albireo Pharma’s price range in the past 12 months?
Currently, no data Available
What is Albireo Pharma’s market cap?
Currently, no data Available
When is Albireo Pharma’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Albireo Pharma’s earnings last quarter?
Currently, no data Available
Is Albireo Pharma overvalued?
According to Wall Street analysts Albireo Pharma’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
    Does Albireo Pharma pay dividends?
    Albireo Pharma does not currently pay dividends.
    What is Albireo Pharma’s EPS estimate?
    Albireo Pharma’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does Albireo Pharma have?
    Currently, no data Available
    What happened to Albireo Pharma’s price movement after its last earnings report?
    Currently, no data Available
    Which hedge fund is a major shareholder of Albireo Pharma?
    Among the largest hedge funds holding Albireo Pharma’s share is Perceptive Advisors LLC. It holds Albireo Pharma’s shares valued at 38M.


      Albireo Pharma Stock Smart Score

      The Albireo Pharma stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
      Learn more about TipRanks Smart Score

      Company Description

      Albireo Pharma

      Albireo Pharma, Inc. is a pharmaceutical company, which engages in the development and commercialization of bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its product pipeline includes A4250, Elobixibat, and A3384. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA.


      Forecast EPS vs Actual EPS

      Currently, no data available
      Please return soon. This page is being updated.

      Similar Stocks
      Price & Change
      Eagle Pharmaceuticals
      Arcturus Therapeutics
      Vigil Neuroscience Inc

      Popular Stocks

      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis